Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne E Lapi

Showing results (111-120 of 172) with videos related to

Pageof 18
Sort By:
Contrast Media & Molecular Imaging|February 18, 2020
Radiolabeled Cationic Peptides for Targeted Imaging of InfectionTolulope A Aweda, Zumrut F B Muftuler, Adriana V F Massicano, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 29, 2025
Granzyme B PET Imaging Predicts Response to Immunotherapy in a Diet-Induced Obesity Model of Breast CancerShannon E Lynch, Corinne Crawford, Addison L Hunt, et al.
Molecules (Basel, Switzerland)|April 3, 2021
[<sup>89</sup>Zr]-Pertuzumab PET Imaging Reveals Paclitaxel Treatment Efficacy Is Positively Correlated with HER2 Expression in Human Breast Cancer Xenograft Mouse ModelsYun Lu, Meng Li, Adriana V F Massicano, et al.
Cancers|February 25, 2022
Modulation of the Tumor Microenvironment with Trastuzumab Enables Radiosensitization in HER2+ Breast CancerPatrick N Song, Ameer Mansur, Yun Lu, et al.
Scientific Reports|April 2, 2025
PET imaging of differentiated thyroid cancer with thyrotropin-alfaGrayson R Gimblet, Pratheek Reddy, Michelle M Holland, et al.
Molecular Pharmaceutics|July 8, 2024
PET Imaging of Differentiated Thyroid Cancer with TSHR-Targeted [<sup>89</sup>Zr]Zr-TR1402Grayson R Gimblet, Hailey A Houson, Jason Whitt, et al.
Frontiers in Immunology|December 19, 2024
SON-1010: an albumin-binding IL-12 fusion protein that improves cytokine half-life, targets tumors, and enhances therapeutic efficacyJohn K Cini, Richard T Kenney, Susan Dexter, et al.
Surgery|October 21, 2019
Overexpression of somatostatin receptor type 2 in neuroendocrine tumors for improved Ga68-DOTATATE imaging and treatmentRachael Guenter, Tolulope Aweda, Danilea M Carmona Matos, et al.
Analytical Chemistry|September 26, 2015
Harvesting (67)Cu from the Collection of a Secondary Beam Cocktail at the National Superconducting Cyclotron LaboratoryTara Mastren, Aranh Pen, Shaun Loveless, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 25, 2019
Imaging of HER2 with [<sup>89</sup>Zr]pertuzumab in Response to T-DM1 TherapyAdriana V F Massicano, Supum Lee, Bryant K Crenshaw, et al.
Pageof 18

Showing results (111-120 of 172) with videos related to

Sort By:
Pageof 18
Contrast Media & Molecular Imaging|February 18, 2020
Radiolabeled Cationic Peptides for Targeted Imaging of InfectionTolulope A Aweda, Zumrut F B Muftuler, Adriana V F Massicano, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 29, 2025
Granzyme B PET Imaging Predicts Response to Immunotherapy in a Diet-Induced Obesity Model of Breast CancerShannon E Lynch, Corinne Crawford, Addison L Hunt, et al.
Molecules (Basel, Switzerland)|April 3, 2021
[<sup>89</sup>Zr]-Pertuzumab PET Imaging Reveals Paclitaxel Treatment Efficacy Is Positively Correlated with HER2 Expression in Human Breast Cancer Xenograft Mouse ModelsYun Lu, Meng Li, Adriana V F Massicano, et al.
Cancers|February 25, 2022
Modulation of the Tumor Microenvironment with Trastuzumab Enables Radiosensitization in HER2+ Breast CancerPatrick N Song, Ameer Mansur, Yun Lu, et al.
Scientific Reports|April 2, 2025
PET imaging of differentiated thyroid cancer with thyrotropin-alfaGrayson R Gimblet, Pratheek Reddy, Michelle M Holland, et al.
Molecular Pharmaceutics|July 8, 2024
PET Imaging of Differentiated Thyroid Cancer with TSHR-Targeted [<sup>89</sup>Zr]Zr-TR1402Grayson R Gimblet, Hailey A Houson, Jason Whitt, et al.
Frontiers in Immunology|December 19, 2024
SON-1010: an albumin-binding IL-12 fusion protein that improves cytokine half-life, targets tumors, and enhances therapeutic efficacyJohn K Cini, Richard T Kenney, Susan Dexter, et al.
Surgery|October 21, 2019
Overexpression of somatostatin receptor type 2 in neuroendocrine tumors for improved Ga68-DOTATATE imaging and treatmentRachael Guenter, Tolulope Aweda, Danilea M Carmona Matos, et al.
Analytical Chemistry|September 26, 2015
Harvesting (67)Cu from the Collection of a Secondary Beam Cocktail at the National Superconducting Cyclotron LaboratoryTara Mastren, Aranh Pen, Shaun Loveless, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 25, 2019
Imaging of HER2 with [<sup>89</sup>Zr]pertuzumab in Response to T-DM1 TherapyAdriana V F Massicano, Supum Lee, Bryant K Crenshaw, et al.
Pageof 18